WoS İndeksli Yayınlar Koleksiyonu
Permanent URI for this collectionhttps://hdl.handle.net/20.500.12573/394
Browse
3 results
Search Results
Conference Object Citation - WoS: 1Citation - Scopus: 1Prediction of Type 2 Diabetes Using Metagenomic Data and Identification of Taxonomic Biomarkers(IEEE, 2024-05-15) Temiz, Mustafa; Kuzudisli, Cihan; Yousef, Malik; Bakir-Gungor, BurcuNowadays, different molecular levels of -omics data on diseases are generated and analyzing these data with machine learning methods is one of the popular research topics. Among these data, the use of metagenomic data to facilitate the diagnosis, detection and treatment of diseases is increasing day by day. Type 2 diabetes (T2D) is a chronic disease characterized by insulin resistance and progressive dysfunction of pancreatic beta cells. While the number of people with diabetes is increasing by around 8% annually, the cost of treating the disease is rising by 18% per year. Therefore, the number of studies on the diagnosis, development and progression of T2D is increasing over time. The aim of this study is to achieve higher machine learning performance by using fewer metagenomic features and to achieve better classification performance by reducing computational costs. In this study, we compare the performance of three different methods using T2D-related metagenomic data. First, the MetaPhlAn tool is used to calculate the taxonomic species and their relative abundances in each sample. The SVM-RCE, RCE-IFE and microBiomeGSM tools used in this study are methods that perform classification by grouping and scoring features and are known to work well on complex datasets. In this study, the best results were obtained with the RCE-IFE tool with an AUC of 0.72 with an average of 125 features information. In addition, key taxonomic species identified by these tools as associated with T2D are presented in comparison to the literature.Conference Object Metagenomic Data Analysis With Machine Learning to Discover Colorectal Cancer-Associated Enzymes(IEEE, 2024-05-15) Ersoz, Nur Sebnem; Kuzudisli, Cihan; Yousef, Malik; Bakir-Gungor, BurcuThe human gut microbiome comprises over 10 trillion microbes and plays important roles in maintaining metabolism, body homeostasis, impacting immune function. Metagenomics which studies genomic data from clinical and environmental samples is crucial in understanding the interplay between the host and the gut microbiome. Recently, functional profiling of metagenomes helps to identify alterations in microbial functions, particularly enzyme-encoding genes. Colorectal cancer (CRC) is known as one of the leading causes of cancer-related deaths. In this study, we aimed to find the CRC-associated enzymes by analyzing metagenomic data with different machine learning methods. A total of 1262 samples including CRC and control groups from different countries were used in this study. This dataset was obtained by functionally profiling metagenomics data and estimating community level enzyme commission (EC) abundance values. For the analysis of this dataset, RCE-IFE and SVM-RCE machine learning methods, which are group-based feature selection methods, were compared with 6 different individual feature selection methods. 10 times Monte-Carlo Cross Validation was used in our experiments. It was observed that RCE-IFE, Extreme Gradient Boosting and Select K Best methods similarly provided the best performances. Especially in this study, besides the its high performance, the group-based feature selection method RCE-IFE grouped enzymes into clusters unlike TFS, and then identified biologically relevant CRC-associated enzymes.Conference Object İmmün Bağlantılı Hastalıklarda Aktif Alt Ağ Araması ile Ortak Hastalık Oluşum Mekanizmalarının Tespiti(IEEE, 2020-09) Eryilmaz, Mahmut Kaan; Kuzudisli, Cihan; Gungor, Burcu BakirDifferent, but related diseases often contain shared symptoms indicating the presence of possible overlaps in underlying pathogenic mechanisms. The identification of the shared pathways and related factors across these diseases helps to better understand the causes of these diseases, to prevent and treat these diseases. In this study, using immune-related diseases, we proposed a new method on how to compare the development mechanisms of related diseases based on biological pathways. Following the developments in genomic technologies, the genotyping gets cheaper and easier, and hence genome-wide association studies (GWAS) emerged. By this means, via studying big-sized case-control groups for a specific disease, potential genetic variations, single nucleotide polymorphisms (SNPs) could he identified. With the help of these studies, in which around a million of SNPs are scanned, the variations and genes that could have a role in specific disease development could be detected. In this study, via using available GWAS datasets and human protein-protein interaction network, and via detecting active subnetworks and affected pathways, seven immune related diseases are analyzed. Via investigating the similarities among the identified pathways for related diseases, we aim to define the underlying pathogenic mechanisms, and hence to contribute to the elucidation of disease development mechanisms and to the drug repositioning studies.